Cisplatin, the Timeless Molecule
Cisplatin was the first metal-based anticancer drug introduced into clinical use. It is a “small” molecule, but it represented a very “big” discovery. Since it was introduced on the market, it has not been withdrawn, despite being not free of side effects, owing to its peculiarity of being highly ef...
Saved in:
| Main Authors: | Annaluisa Mariconda, Jessica Ceramella, Alessia Catalano, Carmela Saturnino, Maria Stefania Sinicropi, Pasquale Longo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Inorganics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2304-6740/13/7/246 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Silver <i>N</i>-Heterocyclic Carbene (NHC) Complexes as Antimicrobial and/or Anticancer Agents
by: Jessica Ceramella, et al.
Published: (2024-12-01) -
Chitosan-Based Schiff Bases (CSBs) and Their Metal Complexes: Promising Antimicrobial Agents
by: Domenico Iacopetta, et al.
Published: (2025-01-01) -
Cisplatin and the Dissolution of Electrodes in Electrochemistry Experiments
by: Ross Milton, et al.
Published: (2025-02-01) -
Cisplatin‐Induced Muscle Wasting and Atrophy: Molecular Mechanism and Potential Therapeutic Interventions
by: Ko‐Chieh Huang, et al.
Published: (2025-06-01) -
Aldehydes: What We Should Know About Them
by: Alessia Catalano, et al.
Published: (2024-10-01)